Published: 21 December 2021
Author(s): José Miguel Rivera-Caravaca, Wern Yew Ding, Francisco Marín, Vanessa Roldán, Gregory Y.H. Lip, Christina J.-Y. Lee MD, PhD; Christian Torp-Pedersen MD, DMSc
Issue: April 2022
Section: Letter to the Editor

The CHA2DS2-VASc score is one of the most validated risk tools in atrial fibrillation (AF) [1], and remains a simple and practical clinical score to aid decision-making. However, it has limitations in predicting the absolute stroke risk and its ability for identifying patients at risk of thromboembolism is modest.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.